KHIDI Korean Pavilion for ‘HIMSS Europe Digital Event’

HELSINKI, Sept. 3, 2020 /PRNewswire/ — Korea Health Industry Development Institute (KHIDI) is planning to participate in ‘HIMSS & Health 2.0 European Digital Event’ held for 5 days from September 7th to 11th, 2020 with competitive digital healthcare companies in Korea.

KHIDI is the government-affiliated institution which carries out the systematic and professional support for the improvement of public health and enhancement of the international competitiveness in the health industry. KHIDI has been specifically leading the development of the health industry such as medical services, pharmaceuticals, medical devices, foreign patient attraction, and digital healthcare industry.

In particular, in the HIMSS European event, the Korea Pavilion was operated by recruiting companies for three consecutive years following 2018 and 2019. Even for this upcoming event, eight competitive Korean companies will be participating online.

The enterprises with outstanding technology including Lemonhealthcare, F&D Partners, Mediage, Doai, Ikoob, U-Shin C&C, Insung information, QTT etc., will be showcasing their unique technologies such as medical device manufacturing, remote medical treatment system and medical software.

Deok-Cheol Kwon, the president of KHIDI stated that he hopes that Korea’s competitive companies and companies around the world will have a constructive forum for discussion on the promotion of human health and the development of the smart healthcare industry at HIMSS European digital event.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/khidi-korean-pavilion-for-himss-europe-digital-event-301122605.html

SOURCE Korea Health Industry Development Institute

Staff

Recent Posts

SJTU International Gen Z Students Explore Shanghai’s Innovation Ecosystem

SHANGHAI, Dec. 8, 2025 /PRNewswire/ -- Shanghai Jiao Tong University's Antai Global Summer Program (AGSP)…

21 minutes ago

Evotec Closes Sale of Just – Evotec Biologics’ Toulouse Site to Sandoz

All closing requirements satisfied following announcement of a non-binding term-sheet agreement in July and signing…

3 hours ago

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health…

6 hours ago

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment…

6 hours ago

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…

21 hours ago